These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 23117149)
1. The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis. Yang J; Zhong J; Xiao XH; Zhou LZ; Chen YJ; Liu JH; Cao RX; Wen GB Endocr J; 2013; 60(2):185-9. PubMed ID: 23117149 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years. Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063 [TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis. Dai WX; Zhang JD; Zhan SW; Xu BZ; Jin H; Yao Y; Xin WC; Bai Y Endocr J; 2002 Feb; 49(1):29-33. PubMed ID: 12008747 [TBL] [Abstract][Full Text] [Related]
4. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Balkin MS; Buchholtz M; Ortiz J; Green AJ Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment. Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564 [TBL] [Abstract][Full Text] [Related]
7. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs]. Dai W; Zhang J; Zhan Z; Xu B; Jin H Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711 [TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis. Murakami Y; Sasaki I; Hiraiwa T; Arishima T; Ito M; Hanafusa T; Sakane S; Ohsawa N; Takamatsu J; Miyauchi A; Kuma K Endocr J; 2004 Dec; 51(6):579-85. PubMed ID: 15644577 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia. Tajiri J; Noguchi S; Murakami N Thyroid; 1997 Aug; 7(4):575-8. PubMed ID: 9292945 [TBL] [Abstract][Full Text] [Related]
10. Increased risk for thionamide-induced agranulocytosis in elderly patients: a case presentation and literature review. Bukhari S; Khan M; Kumar N; Mohan V BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28716776 [TBL] [Abstract][Full Text] [Related]
11. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. Watanabe N; Narimatsu H; Noh JY; Yamaguchi T; Kobayashi K; Kami M; Kunii Y; Mukasa K; Ito K; Ito K J Clin Endocrinol Metab; 2012 Jan; 97(1):E49-53. PubMed ID: 22049174 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Tajiri J; Noguchi S; Okamura S; Morita M; Tamaru M; Murakami N; Niho Y Arch Intern Med; 1993 Feb; 153(4):509-14. PubMed ID: 7679571 [TBL] [Abstract][Full Text] [Related]
13. Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis. Apinantriyo B; Lekhakula A; Rujirojindakul P Hematology; 2011 Jan; 16(1):50-3. PubMed ID: 21269568 [TBL] [Abstract][Full Text] [Related]
14. Agranulocytosis induced by antithyroid therapy: effects of treatment with granulocyte colony stimulating factor. Adorf D; Grajer KH; Kaboth W; Nerl C Clin Investig; 1994 May; 72(5):390-2. PubMed ID: 7522068 [TBL] [Abstract][Full Text] [Related]
15. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism. Zhu D; Zhang S; Cao X; Xia Q; Zhang Q; Deng D; Gao S; Yu H; Liu Y; Zhou H; Tao F; Sun X Endocr Pract; 2021 Dec; 27(12):1183-1188. PubMed ID: 34216800 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Fukata S; Kuma K; Sugawara M Thyroid; 1999 Jan; 9(1):29-31. PubMed ID: 10037073 [TBL] [Abstract][Full Text] [Related]
17. Antithyroid drugs. Cooper DS N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981 [No Abstract] [Full Text] [Related]
18. Sudden onset agranulocytosis and hepatotoxicity after taking methimazole. Yang J; Zhong J; Zhou LZ; Hong T; Xiao XH; Wen GB Intern Med; 2012; 51(16):2189-92. PubMed ID: 22892501 [TBL] [Abstract][Full Text] [Related]
19. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. Meyer-Gessner M; Benker G; Lederbogen S; Olbricht T; Reinwein D J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356 [TBL] [Abstract][Full Text] [Related]
20. Antithyroid drug-induced agranulocytosis: report of 13 cases. Huang CH; Li KL; Wu JH; Wang PN; Juang JH Chang Gung Med J; 2007; 30(3):242-8. PubMed ID: 17760275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]